InvestorsHub Logo

cowtown jay

09/23/21 10:27 AM

#33564 RE: The Other Guy #33563

"The manufacturing expense included in R&D was $57.1 million for the second quarter..."

https://ir.humanigen.com/English/news/news-details/Q/Humanigen-Reports-Second-Quarter-2021-Financial-Results/default.aspx

We know they scaled back in Q3, but not by how much. I was told they could have preserved 10's of millions of dollars, if the FDA had announced our decline decision earlier than 103 days.

DonDonDonDon

09/23/21 10:45 AM

#33566 RE: The Other Guy #33563

CD said they intend to “extend the runway.” This can be interpreted in multiple ways. Thoughts?


Manufacturing is going to be slowed unless an approval comes from somewhere soon. It is unfortunate.